Not Community-Associated Methicillin-Resistant Staphylococcus aureus (CA-MRSA)! A Clinician's Guide to Community MRSA - Its Evolving Antimicrobial Resistance and Implications for Therapy
Open Access
- 1 January 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 52 (1), 99-114
- https://doi.org/10.1093/cid/ciq067
Abstract
There is significant diversity in methicillin-resistant Staphylococcus aureus (MRSA) clones arising in the community worldwide, with considerable geographical differences in typical antimicrobial resistance profiles. Many community clones of MRSA have a non–multidrug resistant antimicrobial profile, providing increased options for empirical and directed therapy of infections caused by these strains. However, the recent description of increasing non–β lactam resistance in community clones of MRSA, especially USA300, provides a timely warning for clinicians making decisions about therapy for patients potentially infected with these strains. Continued monitoring of global epidemiology and emerging drug resistance data is critical for the effective management of these infections.Keywords
This publication has 106 references indexed in Scilit:
- Emergence of Resistance among USA300 Methicillin-Resistant Staphylococcus aureus Isolates Causing Invasive Disease in the United StatesAntimicrobial Agents and Chemotherapy, 2010
- Community-associated meticillin-resistant Staphylococcus aureusThe Lancet, 2010
- Antibody-mediated enhancement of community-acquired methicillin-resistant Staphylococcus aureus infectionProceedings of the National Academy of Sciences of the United States of America, 2010
- Dissemination of Methicillin‐ResistantStaphylococcus aureusUSA300 Sequence Type 8 Lineage in Latin AmericaClinical Infectious Diseases, 2009
- Waves of resistance: Staphylococcus aureus in the antibiotic eraNature Reviews Microbiology, 2009
- Emergence of community-acquired meticillin-resistant Staphylococcus aureus strain USA300 as a cause of necrotising community-onset pneumoniaThe Lancet Infectious Diseases, 2009
- Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolatesJournal of Antimicrobial Chemotherapy, 2008
- Community-associated methicillin-resistant and methicillin-sensitive Staphylococcus aureus: skin and soft tissue infections in Hong KongDiagnostic Microbiology and Infectious Disease, 2008
- Tetracyclines as an Oral Treatment Option for Patients with Community Onset Skin and Soft Tissue Infections Caused by Methicillin-Resistant Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2007
- Prospective Randomized Trial of Empiric Therapy with Trimethoprim-Sulfamethoxazole or Doxycycline for Outpatient Skin and Soft Tissue Infections in an Area of High Prevalence of Methicillin-Resistant Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2007